Breast Cancer - First-in-Class Innovation Underlies Immunoth

Breast Cancer - First-in-Class Innovation Underlies Immunoth'

Caption: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

Credit: Market Research Reports, Inc.

Related Press Releases

Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer; New Report Launched

Link to this Photo

Email & IM:

Direct Link:

HTML Code:

IMG Code:

Download Photo

Photo Information

Release date:
Monday Aug 27, 2018

Release time:
02:28 am

Width::
607px

Height::
512px

Size::
103 KB

Share